By integrating microbiome research with data-driven biotechnology,
we discover innovative functional materials that regulate various human metabolic functions.
LuxBiome pursues both scientific validation and global scalability based on
over 30 years of microbial research expertise and our AI-driven genome analysis platform, PangenomeMiner™.
We are committed to growing into a global biotech leader that enables people worldwide to lead healthier lives
through R&D grounded in rigorous science and data.
Thank you.
LuxBiome Co., Ltd.

Cumulative Research Fund
KRW 38.5 Billion

SCI Papers
242

Patents Filed & Registered
55